Skip to main content
Clinical Trials/NCT02243397
NCT02243397CompletedNot Applicable

Molecular and Cellular Analysis of Breast Cancer

Stanford University1 site in 1 country145 target enrollmentStarted: September 10, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
145
Locations
1
Primary Endpoint
levels of GM-CSF in plasma

Study Overview

Brief Summary

The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Minutes to — (Child, Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary consistent with the presentation of a primary breast malignancy.
  • 18 years of age or older.
  • Ability to understand and the willingness to sign a written informed consent do

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

levels of GM-CSF in plasma

Time Frame: 10 years

We will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kathleen Horst

Kathleen Horst MD

Stanford University

Study Sites (1)

Loading locations...

Similar Trials